499 related articles for article (PubMed ID: 26822237)
1. Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.
Parsons DW; Roy A; Yang Y; Wang T; Scollon S; Bergstrom K; Kerstein RA; Gutierrez S; Petersen AK; Bavle A; Lin FY; López-Terrada DH; Monzon FA; Hicks MJ; Eldin KW; Quintanilla NM; Adesina AM; Mohila CA; Whitehead W; Jea A; Vasudevan SA; Nuchtern JG; Ramamurthy U; McGuire AL; Hilsenbeck SG; Reid JG; Muzny DM; Wheeler DA; Berg SL; Chintagumpala MM; Eng CM; Gibbs RA; Plon SE
JAMA Oncol; 2016 May; 2(5):616-624. PubMed ID: 26822237
[TBL] [Abstract][Full Text] [Related]
2. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
3. Molecular findings among patients referred for clinical whole-exome sequencing.
Yang Y; Muzny DM; Xia F; Niu Z; Person R; Ding Y; Ward P; Braxton A; Wang M; Buhay C; Veeraraghavan N; Hawes A; Chiang T; Leduc M; Beuten J; Zhang J; He W; Scull J; Willis A; Landsverk M; Craigen WJ; Bekheirnia MR; Stray-Pedersen A; Liu P; Wen S; Alcaraz W; Cui H; Walkiewicz M; Reid J; Bainbridge M; Patel A; Boerwinkle E; Beaudet AL; Lupski JR; Plon SE; Gibbs RA; Eng CM
JAMA; 2014 Nov; 312(18):1870-9. PubMed ID: 25326635
[TBL] [Abstract][Full Text] [Related]
4. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing.
Wang J; Xi Z; Xi J; Zhang H; Li J; Xia Y; Yi Y
Cancer Cell Int; 2018; 18():159. PubMed ID: 30349421
[TBL] [Abstract][Full Text] [Related]
6. Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle.
Lin FY; Bergstrom K; Person R; Bavle A; Ballester LY; Scollon S; Raesz-Martinez R; Jea A; Birchansky S; Wheeler DA; Berg SL; Chintagumpala MM; Adesina AM; Eng C; Roy A; Plon SE; Parsons DW
Cold Spring Harb Mol Case Stud; 2016 Sep; 2(5):a001057. PubMed ID: 27626068
[TBL] [Abstract][Full Text] [Related]
7. Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations.
Sprissler R; Perkins B; Johnstone L; Babiker HM; Chalasani P; Lau B; Hammer M; Mahadevan D
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32570879
[TBL] [Abstract][Full Text] [Related]
8. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract][Full Text] [Related]
9. Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients.
Scollon S; Bergstrom K; Kerstein RA; Wang T; Hilsenbeck SG; Ramamurthy U; Gibbs RA; Eng CM; Chintagumpala MM; Berg SL; McCullough LB; McGuire AL; Plon SE; Parsons DW
Genome Med; 2014; 6(9):69. PubMed ID: 25317207
[TBL] [Abstract][Full Text] [Related]
10. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.
Meric-Bernstam F; Brusco L; Daniels M; Wathoo C; Bailey AM; Strong L; Shaw K; Lu K; Qi Y; Zhao H; Lara-Guerra H; Litton J; Arun B; Eterovic AK; Aytac U; Routbort M; Subbiah V; Janku F; Davies MA; Kopetz S; Mendelsohn J; Mills GB; Chen K
Ann Oncol; 2016 May; 27(5):795-800. PubMed ID: 26787237
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes.
Henn J; Spier I; Adam RS; Holzapfel S; Uhlhaas S; Kayser K; Plotz G; Peters S; Aretz S
Hered Cancer Clin Pract; 2019; 17():5. PubMed ID: 30680046
[TBL] [Abstract][Full Text] [Related]
12. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned.
Ghaoui R; Cooper ST; Lek M; Jones K; Corbett A; Reddel SW; Needham M; Liang C; Waddell LB; Nicholson G; O'Grady G; Kaur S; Ong R; Davis M; Sue CM; Laing NG; North KN; MacArthur DG; Clarke NF
JAMA Neurol; 2015 Dec; 72(12):1424-32. PubMed ID: 26436962
[TBL] [Abstract][Full Text] [Related]
13. Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer Therapy.
Schneider BP; Stout LA; Philips S; Schroeder C; Scott SF; Hunter C; Kassem N; Kiel PJ; Radovich M
JCO Precis Oncol; 2020 Nov; 4():1109-1121. PubMed ID: 35050776
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM
JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686
[TBL] [Abstract][Full Text] [Related]
15. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
[TBL] [Abstract][Full Text] [Related]
16. Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.
Newman S; Nakitandwe J; Kesserwan CA; Azzato EM; Wheeler DA; Rusch M; Shurtleff S; Hedges DJ; Hamilton KV; Foy SG; Edmonson MN; Thrasher A; Bahrami A; Orr BA; Klco JM; Gu J; Harrison LW; Wang L; Clay MR; Ouma A; Silkov A; Liu Y; Zhang Z; Liu Y; Brady SW; Zhou X; Chang TC; Pande M; Davis E; Becksfort J; Patel A; Wilkinson MR; Rahbarinia D; Kubal M; Maciaszek JL; Pastor V; Knight J; Gout AM; Wang J; Gu Z; Mullighan CG; McGee RB; Quinn EA; Nuccio R; Mostafavi R; Gerhardt EL; Taylor LM; Valdez JM; Hines-Dowell SJ; Pappo AS; Robinson G; Johnson LM; Pui CH; Ellison DW; Downing JR; Zhang J; Nichols KE
Cancer Discov; 2021 Dec; 11(12):3008-3027. PubMed ID: 34301788
[TBL] [Abstract][Full Text] [Related]
17. Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion
Vidula N; Rich TA; Sartor O; Yen J; Hardin A; Nance T; Lilly MB; Nezami MA; Patel SP; Carneiro BA; Fan AC; Brufsky AM; Parker BA; Bridges BB; Agarwal N; Maughan BL; Raymond VM; Fairclough SR; Lanman RB; Bardia A; Cristofanilli M
Clin Cancer Res; 2020 Jun; 26(11):2546-2555. PubMed ID: 32034076
[TBL] [Abstract][Full Text] [Related]
18. Clinical Impact and Cost-Effectiveness of Whole Exome Sequencing as a Diagnostic Tool: A Pediatric Center's Experience.
Valencia CA; Husami A; Holle J; Johnson JA; Qian Y; Mathur A; Wei C; Indugula SR; Zou F; Meng H; Wang L; Li X; Fisher R; Tan T; Hogart Begtrup A; Collins K; Wusik KA; Neilson D; Burrow T; Schorry E; Hopkin R; Keddache M; Harley JB; Kaufman KM; Zhang K
Front Pediatr; 2015; 3():67. PubMed ID: 26284228
[TBL] [Abstract][Full Text] [Related]
19. Nearly Half of
Diessner BJ; Pankratz N; Hooten AJ; Mirabello L; Sarver AL; Mills LJ; Malkin D; Kelley AC; Spector LG
JCO Precis Oncol; 2020; 4():. PubMed ID: 33163847
[TBL] [Abstract][Full Text] [Related]
20. Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.
Ong PY; Poon SL; Tan KT; Putti TC; Ow SGW; Chen SJ; Chen CH; Lee SC
Gynecol Oncol; 2019 Nov; 155(2):275-279. PubMed ID: 31481248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
